Comment in

• Incretin therapy: should adverse consequences have been anticipated?

  Gale E. Gale E. BMJ. 2013 Jun 10;346:f3617. doi: 10.1136/bmj.f3617. BMJ. 2013. PMID: 23751905 No abstract available.
• The BMJ and Dispatches gave only one side of the story.

  Holt RI. Holt RI. BMJ. 2013 Jul 10;347:f4379. doi: 10.1136/bmj.f4379. BMJ. 2013. PMID: 23842432 No abstract available.
• Cardiovascular benefits of incretins.

  Barnett AH, O'Hare P. Barnett AH, et al. BMJ. 2013 Jul 10;347:f4382. doi: 10.1136/bmj.f4382. BMJ. 2013. PMID: 23842433 No abstract available.
• Investigations editor's reply to Holt and to Barnett and O'Hare.

  Cohen D. Cohen D. BMJ. 2013 Jul 10;347:f4383. doi: 10.1136/bmj.f4383. BMJ. 2013. PMID: 23842434 No abstract available.